Hepatitis C Virus Infection and the New Therapeutical Approach
- PMID: 35003766
- PMCID: PMC8679141
- DOI: 10.12865/CHSJ.47.03.04
Hepatitis C Virus Infection and the New Therapeutical Approach
Abstract
Hepatitis C virus represents one of the most important public health problems nowadays. Several epidemiological studies have shown a continuous increasing rate of prevalence and incidence with severe consequences in terms of mortality. During the last decades, the treatment of the liver infection has evolved, and now there are available new therapies with better side-effect' profiles and bigger efficiency. The needs for more therapeutically efficacy also stand behind the numerous comorbidities associated to the liver disease, and also for assuring better quality of life for patients and their families.
Keywords: DAAs therapies; HCV infection; comorbidities; health-related quality of life; interferon.
Copyright © 2014, Medical University Publishing House Craiova.
Conflict of interest statement
None to declare.
Figures





Similar articles
-
Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.J Epidemiol Biostat. 2001;6(3):243-65; discussion 279-85. J Epidemiol Biostat. 2001. PMID: 11437088
-
Hepatitis C, stigma and cure.World J Gastroenterol. 2013 Oct 28;19(40):6703-9. doi: 10.3748/wjg.v19.i40.6703. World J Gastroenterol. 2013. PMID: 24187444 Free PMC article.
-
Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia.J Hepatol. 2019 Aug;71(2):281-288. doi: 10.1016/j.jhep.2019.04.014. Epub 2019 May 10. J Hepatol. 2019. PMID: 31078544
-
Recent advances in the treatment of hepatitis C virus infection for special populations and remaining problems.J Gastroenterol Hepatol. 2021 May;36(5):1152-1158. doi: 10.1111/jgh.15189. Epub 2020 Jul 28. J Gastroenterol Hepatol. 2021. PMID: 32667068 Review.
-
Benefits of curing hepatitis C infection.J Gastrointestin Liver Dis. 2014 Mar;23(1):85-90. J Gastrointestin Liver Dis. 2014. PMID: 24689102 Review.
References
-
- Simmonds P. Genetic diversity and evolution of hepatitis C virus-15 years on. J Gen Virol. 2004;85(Pt11):3173–3188. - PubMed
-
- Hoofnagle JH. Course and outcome of hepatitis C. Hepatology. 2002;36(5 Suppl 1):S21–9. - PubMed
-
- WHO Global Hepatitis Report 2017. Available from: https:// www.who.int/hepatitis/publications/global-hepatitis-report2017/en/ [Accessed 10.06.2021]
-
- Institute of Medicine (US) Committee on the Prevention and Control of Viral Hepatitis Infection . In: Colvin HM, Mitchell AE, editors. Washington (DC): National Academies Press (US); 2010. Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C. - PubMed
LinkOut - more resources
Full Text Sources